Pomerantz law firm announces the filing of a class action against altimmune, inc. and certain officers - alt

New york , may 6, 2024 /prnewswire/ -- pomerantz llp announces that a class action lawsuit has been filed against altimmune, inc. ("altimmune" or the "company") (nasdaq: alt) and certain officers. the class action, filed in the united states district court for the district of maryland, southern division, and docketed under 24-cv-01315, is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired altimmune securities between december 1, 2023 and april 26, 2024, both dates inclusive (the "class period"), seeking to recover damages caused by defendants' violations of the federal securities laws and to pursue remedies under sections 10(b) and 20(a) of the securities exchange act of 1934 (the "exchange act") and rule 10b-5 promulgated thereunder, against the company and certain of its top officials.
ALT Ratings Summary
ALT Quant Ranking